Trial Profile
A phase III trial of granisetron intranasal in patients with acute or delayed chemotherapy-induced nausea and vomiting.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2011
Price :
$35
*
At a glance
- Drugs Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Registrational; Therapeutic Use
- Sponsors Shin Nippon Biomedical Laboratories
- 19 Aug 2010 New trial record